A jury has ordered Johnson & Johnson to pay $1.75 million to a young man that developed breasts while taking the J&J drug Risperdal. The plaintiff in this case alleged the pharmaceutical giant failed to provide proper warning about the risks associated with their drug,... Read More

Since its founding in 1886 by three brothers, Johnson & Johnson has become a globally recognized brand. Johnson & Johnson portrays itself as the go-to brand for family-friendly products, from its 1894 launch of maternity kits to make childbirth safer to the 1954 release of... Read More

A new study has confirmed the link between Risperdal and gynecomastia, even as the number of lawsuits involving this drug continue to be filed. The recent study found a statistically significant risk of male breast growth in young men and male adolescents that took this antipsychotic.... Read More

An article that appeared in a reputable medical journal in 2003 was “manipulated” by the manufacturer of Risperdal, a former FDA chief alleges. Dr. David Kessler, a pediatrician and former head of the FDA, stated in a report filed in U.S. court that Janssen “controlled... Read More

Another Risperdal lawsuit was filed on March 27 by a plaintiff who contends that he developed abnormal male breast growth while taking medication to control symptoms of ADHD and bipolar disorder as a minor. The case was filed in the United States District Court for the... Read More

A Risperdal lawsuit has been filed against the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA), as well as key officials in those departments. The complaint, which was filed by a Pennsylvania law firm, alleges these agencies... Read More

On Friday, March 20 a young man achieved a partial victory in his Risperdal lawsuit against Johnson & Johnson’s Janssen Pharmaceuticals. The 19-year-old plaintiff, William Cirba, of Pennsylvania claimed the company failed to warn patients and the medical community that the antipsychotic drug could cause... Read More

A Philadelphia jury has decided that Johnson & Johnson must pay $2.5 million in damages for failing to warn patients of the link between Risperdal and male breasts. The antipsychotic drug can cause gynecomastia — the abnormal development of breasts in males. This particular lawsuit... Read More